Indication
Anemia in myelodysplastic syndrome with ring sideroblasts
Anemia in myelodysplastic syndrome with ring sideroblasts is a hematologic manifestation of a clonal hematopoietic stem cell neoplasm primarily affecting older adults. Read more about Anemia in myelodysplastic syndrome with ring sideroblasts
2 drugs 2 manufacturers
Drugs that treat it
Common Anemia in myelodysplastic syndrome with ring sideroblasts therapies.
REBLOZYL (luspatercept-aamt)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnemia in myelodysplastic syndrome with ring sideroblasts is a hematologic manifestation of a clonal hematopoietic stem cell neoplasm primarily affecting older adults.
It is characterized by ineffective erythropoiesis that results in chronic peripheral cytopenia and potential transfusion dependence.
Pathophysiologically, the condition is defined by the accumulation of iron within the mitochondria of erythroid precursors, visible on bone marrow evaluation as a collar of perinuclear iron granules encircling at least one-third of the nucleus.
This subtype is frequently driven by somatic mutations in the RNA splicing machinery gene *SF3B1*, which lead to abnormal mitochondrial iron handling, maturation arrest in late-stage erythroblasts, and a heightened risk of secondary systemic iron overload.
- nih.gov
Anemia in myelodysplastic syndrome with ring sideroblasts is a hematologic manifestation of a clonal hematopoietic stem cell neoplasm primarily affecting older adults It is characterized by ineffective erythropoiesis that results in chronic peripheral cytopenia and potential transfusion dependence
- mdanderson.org
Anemia in myelodysplastic syndrome with ring sideroblasts is a hematologic manifestation of a clonal hematopoietic stem cell neoplasm primarily affecting older adults
- nih.gov
It is characterized by ineffective erythropoiesis that results in chronic peripheral cytopenia and potential transfusion dependence Pathophysiologically, the condition is defined by the accumulation of iron within the mitochondria of erythroid precursors, visible on bone marrow evaluation as a collar of perinuclear iron granules encircling at least one-third of the nucleus This subtype is frequently driven by somatic mutations in the RNA splicing machinery gene *SF3B1*, which lead to abnormal mi...
- nih.gov
It is characterized by ineffective erythropoiesis that results in chronic peripheral cytopenia and potential transfusion dependence
- nih.gov
Pathophysiologically, the condition is defined by the accumulation of iron within the mitochondria of erythroid precursors, visible on bone marrow evaluation as a collar of perinuclear iron granules encircling at least one-third of the nucleus
- ashpublications.org
This subtype is frequently driven by somatic mutations in the RNA splicing machinery gene *SF3B1*, which lead to abnormal mitochondrial iron handling, maturation arrest in late-stage erythroblasts, and a heightened risk of secondary systemic iron overload
Personalize your experience
Follow Anemia in myelodysplastic syndrome with ring sideroblasts and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.